Thu, 10 May 2012
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers. Direct download: GRACEcast-100_Lung-Audio_MMiLC_Panel_Discussion_pt5.mp3 Category:Lung-Cancer-Audio -- posted at: 10:22 PM |
Thu, 10 May 2012
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers. Direct download: GRACEcast-100_Lung-Video_MMiLC_Panel_Discussion_pt5.m4v Category:Lung-Cancer-Video -- posted at: 10:21 PM |
Sat, 28 April 2012
Panel discussion with 4 expert thought leaders in lung cancer about how we might best approach testing clinically relevant molecular targets in lung cancer patients. Direct download: GRACEcast-099_Lung-Audio_MMiLC_Panel_Discussion_pt4.mp3 Category:Lung-Cancer-Audio -- posted at: 11:52 PM |
Sat, 28 April 2012
Panel discussion with 4 expert thought leaders in lung cancer about how we might best approach testing clinically relevant molecular targets in lung cancer patients. Direct download: GRACEcast-099_Lung-Video_MMiLC_Panel_Discussion_pt4.m4v Category:Lung-Cancer-Video -- posted at: 11:51 PM |
Mon, 23 April 2012
Panel discussion with 4 expert thought leaders in lung cancer about the prevalence of critical molecular markers in different clinical and histologic groups of lung cancer patients. Direct download: GRACEcast-098_Lung-Audio_MMiLC_Panel_Discussion_pt3.mp3 Category:Lung-Cancer-Audio -- posted at: 2:05 AM |
Mon, 23 April 2012
Panel discussion with 4 expert thought leaders in lung cancer about the prevalence of critical molecular markers in different clinical and histologic groups of lung cancer patients. Direct download: GRACEcast-098_Lung-Video_MMiLC_Panel_Discussion_pt3.m4v Category:Lung-Cancer-Video -- posted at: 2:04 AM |
Sat, 14 April 2012
Dr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology. Direct download: GRACEcast-097_Lung-Audio_MMiLC_Shaw_on_Patterns_pt2.mp3 Category:Lung-Cancer-Audio -- posted at: 11:04 PM |
Sat, 14 April 2012
Dr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology. Direct download: GRACEcast-097_Lung-Video_MMiLC_Shaw_on_Patterns_pt2.m4v Category:Lung-Cancer-Video -- posted at: 11:03 PM |
Fri, 6 April 2012
Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma. Direct download: GRACEcast-096_Lung-Audio_MMiLC_Rudin_on_Consortium_pt1.mp3 Category:Lung-Cancer-Audio -- posted at: 11:58 PM |
Fri, 6 April 2012
Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma. Direct download: GRACEcast-096_Lung-Video_MMiLC_Rudin_on_Consortium_pt1.m4v Category:Lung-Cancer-Video -- posted at: 11:55 PM |

